Pharmacy Times October 15, 2024
Anne Cassity

Legislative efforts in the states and Washington, DC, have made progress, but there is still a way to go.

For the past 15 years or so, independent pharmacy has been pushing consistently for transparency into the business practices of pharmacy benefit managers (PBMs) and reforms to their tactics. Patient steering, spread pricing, take-it-or-leave-it contracts, formulary manipulations, low or below-cost reimbursements, and other schemes have put tremendous pressure on independent pharmacies and patients seeking affordable, accessible care.

When it comes to finalizing reforms, we find ourselves at fourth-and-1. With the help of independent pharmacy team members, patients, and other allies, the ball has been moving ever closer to the goal line in Washington, DC.

Legislatively, the National Community Pharmacists Association (NCPA)...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, Pharma, Pharma / Biotech
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
Survey Suggests Pharma Industry Still Struggling with Digital Transformation
Will Walgreens’ store closures disrupt its clinical trial aims?
340B Legal Challenges Highlight The Appetite For Innovation That Supports The Program’s Goals
How Agencies Should Decide Which Costly Drugs To Target With Government March-In Rights

Share This Article